{"id":6562,"date":"2025-05-30T09:52:06","date_gmt":"2025-05-30T07:52:06","guid":{"rendered":"https:\/\/tresca.es\/tresca-te-informa\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/"},"modified":"2025-05-30T10:26:08","modified_gmt":"2025-05-30T08:26:08","slug":"248-estrategia-de-la-industria-farmaceutica-2024-2028","status":"publish","type":"dlp_document","link":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/","title":{"rendered":"248. PHARMACEUTICAL INDUSTRY STRATEGY 2024-2028"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

The Spanish Government has approved an ambitious National Pharmaceutical Strategy with a horizon until 2028, designed to transform the sector through legislative reforms and an investment of 8 billion euros previously agreed with the main pharmaceutical companies.<\/p>\n","protected":false},"author":1,"featured_media":6559,"comment_status":"open","ping_status":"closed","template":"","meta":[],"dlp_document_ano-publicacion":[191],"doc_categories":[171,172],"doc_tags":[189],"doc_author":[205],"file_type":[198],"class_list":["post-6562","dlp_document","type-dlp_document","status-publish","has-post-thumbnail","hentry","dlp_document_ano-publicacion-2024-en-2","doc_categories-industry","doc_categories-policies","doc_tags-pharmaceutical-industry","doc_author-tresca-ingenieria-en","file_type-pdf-en","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"download_url":false,"file_size":"","filename":false,"download_count":"","version_history":[],"yoast_head":"\n248. PHARMACEUTICAL INDUSTRY STRATEGY 2024-2028 - Tresca<\/title>\n<meta name=\"description\" content=\"The Spanish Government has approved an ambitious National Pharmaceutical Strategy with a horizon until 2028, designed to transform the sector through legislative reforms and an investment of 8 billion euros previously agreed with the main pharmaceutical companies. %\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"248. PHARMACEUTICAL INDUSTRY STRATEGY 2024-2028 - Tresca\" \/>\n<meta property=\"og:description\" content=\"The Spanish Government has approved an ambitious National Pharmaceutical Strategy with a horizon until 2028, designed to transform the sector through legislative reforms and an investment of 8 billion euros previously agreed with the main pharmaceutical companies. %\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/\" \/>\n<meta property=\"og:site_name\" content=\"Tresca\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/grupotrescaesp\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-30T08:26:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tresca.es\/wp-content\/uploads\/2021\/11\/Banner-Principal.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1801\" \/>\n\t<meta property=\"og:image:height\" content=\"769\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/bienvenidos-al-conocimiento\\\/248-estrategia-de-la-industria-farmaceutica-2024-2028\\\/\",\"url\":\"https:\\\/\\\/tresca.es\\\/en\\\/bienvenidos-al-conocimiento\\\/248-estrategia-de-la-industria-farmaceutica-2024-2028\\\/\",\"name\":\"248. PHARMACEUTICAL INDUSTRY STRATEGY 2024-2028 - Tresca\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/bienvenidos-al-conocimiento\\\/248-estrategia-de-la-industria-farmaceutica-2024-2028\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/bienvenidos-al-conocimiento\\\/248-estrategia-de-la-industria-farmaceutica-2024-2028\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tresca.es\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/248.-ESTRATEGIA-DE-LA-INDUSTRIA-FARMACEUTICA-2024-2028-pdf.jpg\",\"datePublished\":\"2025-05-30T07:52:06+00:00\",\"dateModified\":\"2025-05-30T08:26:08+00:00\",\"description\":\"The Spanish Government has approved an ambitious National Pharmaceutical Strategy with a horizon until 2028, designed to transform the sector through legislative reforms and an investment of 8 billion euros previously agreed with the main pharmaceutical companies. %\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/bienvenidos-al-conocimiento\\\/248-estrategia-de-la-industria-farmaceutica-2024-2028\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tresca.es\\\/en\\\/bienvenidos-al-conocimiento\\\/248-estrategia-de-la-industria-farmaceutica-2024-2028\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/bienvenidos-al-conocimiento\\\/248-estrategia-de-la-industria-farmaceutica-2024-2028\\\/#primaryimage\",\"url\":\"https:\\\/\\\/tresca.es\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/248.-ESTRATEGIA-DE-LA-INDUSTRIA-FARMACEUTICA-2024-2028-pdf.jpg\",\"contentUrl\":\"https:\\\/\\\/tresca.es\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/248.-ESTRATEGIA-DE-LA-INDUSTRIA-FARMACEUTICA-2024-2028-pdf.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/bienvenidos-al-conocimiento\\\/248-estrategia-de-la-industria-farmaceutica-2024-2028\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/tresca.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"248. PHARMACEUTICAL INDUSTRY STRATEGY 2024-2028\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/tresca.es\\\/en\\\/\",\"name\":\"Tresca\",\"description\":\"Consultor\u00eda e Ingenier\u00eda\",\"publisher\":{\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tresca.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/#organization\",\"name\":\"Tresca Ingenier\u00eda\",\"url\":\"https:\\\/\\\/tresca.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/tresca.es\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/cropped-logo-AMP-Tresca-120x90-fondo-transparente.png\",\"contentUrl\":\"https:\\\/\\\/tresca.es\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/cropped-logo-AMP-Tresca-120x90-fondo-transparente.png\",\"width\":120,\"height\":40,\"caption\":\"Tresca Ingenier\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/tresca.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/grupotrescaesp\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/tresca-ingenier\u00eda-s-a-\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"248. PHARMACEUTICAL INDUSTRY STRATEGY 2024-2028 - Tresca","description":"The Spanish Government has approved an ambitious National Pharmaceutical Strategy with a horizon until 2028, designed to transform the sector through legislative reforms and an investment of 8 billion euros previously agreed with the main pharmaceutical companies. %","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/","og_locale":"en_US","og_type":"article","og_title":"248. PHARMACEUTICAL INDUSTRY STRATEGY 2024-2028 - Tresca","og_description":"The Spanish Government has approved an ambitious National Pharmaceutical Strategy with a horizon until 2028, designed to transform the sector through legislative reforms and an investment of 8 billion euros previously agreed with the main pharmaceutical companies. %","og_url":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/","og_site_name":"Tresca","article_publisher":"https:\/\/www.facebook.com\/grupotrescaesp","article_modified_time":"2025-05-30T08:26:08+00:00","og_image":[{"width":1801,"height":769,"url":"https:\/\/tresca.es\/wp-content\/uploads\/2021\/11\/Banner-Principal.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/","url":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/","name":"248. PHARMACEUTICAL INDUSTRY STRATEGY 2024-2028 - Tresca","isPartOf":{"@id":"https:\/\/tresca.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/#primaryimage"},"image":{"@id":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/#primaryimage"},"thumbnailUrl":"https:\/\/tresca.es\/wp-content\/uploads\/2025\/05\/248.-ESTRATEGIA-DE-LA-INDUSTRIA-FARMACEUTICA-2024-2028-pdf.jpg","datePublished":"2025-05-30T07:52:06+00:00","dateModified":"2025-05-30T08:26:08+00:00","description":"The Spanish Government has approved an ambitious National Pharmaceutical Strategy with a horizon until 2028, designed to transform the sector through legislative reforms and an investment of 8 billion euros previously agreed with the main pharmaceutical companies. %","breadcrumb":{"@id":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/#primaryimage","url":"https:\/\/tresca.es\/wp-content\/uploads\/2025\/05\/248.-ESTRATEGIA-DE-LA-INDUSTRIA-FARMACEUTICA-2024-2028-pdf.jpg","contentUrl":"https:\/\/tresca.es\/wp-content\/uploads\/2025\/05\/248.-ESTRATEGIA-DE-LA-INDUSTRIA-FARMACEUTICA-2024-2028-pdf.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/tresca.es\/en\/bienvenidos-al-conocimiento\/248-estrategia-de-la-industria-farmaceutica-2024-2028\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/tresca.es\/en\/"},{"@type":"ListItem","position":2,"name":"248. PHARMACEUTICAL INDUSTRY STRATEGY 2024-2028"}]},{"@type":"WebSite","@id":"https:\/\/tresca.es\/en\/#website","url":"https:\/\/tresca.es\/en\/","name":"Tresca","description":"Consultor\u00eda e Ingenier\u00eda","publisher":{"@id":"https:\/\/tresca.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tresca.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/tresca.es\/en\/#organization","name":"Tresca Ingenier\u00eda","url":"https:\/\/tresca.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tresca.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/tresca.es\/wp-content\/uploads\/2021\/10\/cropped-logo-AMP-Tresca-120x90-fondo-transparente.png","contentUrl":"https:\/\/tresca.es\/wp-content\/uploads\/2021\/10\/cropped-logo-AMP-Tresca-120x90-fondo-transparente.png","width":120,"height":40,"caption":"Tresca Ingenier\u00eda"},"image":{"@id":"https:\/\/tresca.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/grupotrescaesp","https:\/\/www.linkedin.com\/company\/tresca-ingenier\u00eda-s-a-\/"]}]}},"builder_content":"","_links":{"self":[{"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/dlp_document\/6562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/dlp_document"}],"about":[{"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/types\/dlp_document"}],"author":[{"embeddable":true,"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/comments?post=6562"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/media\/6559"}],"wp:attachment":[{"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/media?parent=6562"}],"wp:term":[{"taxonomy":"dlp_document_ano-publicacion","embeddable":true,"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/dlp_document_ano-publicacion?post=6562"},{"taxonomy":"doc_categories","embeddable":true,"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/doc_categories?post=6562"},{"taxonomy":"doc_tags","embeddable":true,"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/doc_tags?post=6562"},{"taxonomy":"doc_author","embeddable":true,"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/doc_author?post=6562"},{"taxonomy":"file_type","embeddable":true,"href":"https:\/\/tresca.es\/en\/wp-json\/wp\/v2\/file_type?post=6562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}